fingolimod hydrochloride has been researched along with Aging in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz Diaz, AC; Malone, K; Moore, AC; Shearer, JA; Waeber, C | 1 |
| Farbood, Y; Ghafouri, S; Najafian, SA; Sarkaki, A | 1 |
| Bozdag, G; Mumusoglu, S; Sokmensuer, LK; Suzer, A; Turan, V; Uckan, H | 1 |
| Cooper, BE; Ezzyat, Y; Fielding, RA; McDonald, DJ; Rice, NP; Rivas, DA | 1 |
| Barkhof, F; Cohen, JA; Comi, G; Eckert, B; Francis, G; Häring, DA; Izquierdo, G; Khatri, B; Montalban, X; Pelletier, J | 1 |
| Dominguez, SJ; Garza, NT; Gil-Tommee, C; Medina, D; Perez, RG; Segura-Ulate, I; Vargas-Medrano, J; Vidal-Martínez, G; Yang, B | 1 |
| Bobylev, I; Joshi, A; Lehmann, HC; Ritter, C; Schneider, T; Svačina, MK | 1 |
1 trial(s) available for fingolimod hydrochloride and Aging
| Article | Year |
|---|---|
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
Topics: Adult; Aging; Analysis of Variance; Brain; Data Interpretation, Statistical; Female; Fingolimod Hydrochloride; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Recurrence; Sphingosine; Treatment Outcome | 2013 |
6 other study(ies) available for fingolimod hydrochloride and Aging
| Article | Year |
|---|---|
The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.
Topics: Aging; Animals; Brain Ischemia; Diet, High-Fat; Disease Models, Animal; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; T-Lymphocytes, Regulatory | 2021 |
FTY720 administration following hypoxia-induced neonatal seizure reverse cognitive impairments and severity of seizures in male and female adult rats: The role of inflammation.
Topics: Aging; Animals; Animals, Newborn; Cognitive Dysfunction; Epilepsy; Female; Fingolimod Hydrochloride; Hippocampus; Hypoxia; Inflammation; Male; Neuroprotective Agents; Pentylenetetrazole; Rats; Seizures; Severity of Illness Index | 2021 |
The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model.
Topics: Aging; Animals; Anti-Mullerian Hormone; Apoptosis; Female; Fingolimod Hydrochloride; Ovarian Follicle; Ovary; Rats; Rats, Sprague-Dawley | 2018 |
Sphingosine-1-phosphate analog FTY720 reverses obesity but not age-induced anabolic resistance to muscle contraction.
Topics: Aging; Animals; Cells, Cultured; Diet, High-Fat; Fingolimod Hydrochloride; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Skeletal; Obesity; Random Allocation; Sarcopenia; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators | 2019 |
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.
Topics: Aging; alpha-Synuclein; Animals; Brain-Derived Neurotrophic Factor; Fingolimod Hydrochloride; Gastrointestinal Motility; Humans; Mice; Mice, Transgenic; Parkinson Disease; Protein Precursors | 2016 |
Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study.
Topics: Aging; Animals; Bradycardia; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Telemetry | 2017 |